These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16691156)

  • 1. Development of a nonhuman primate model for Trichomonas vaginalis infection.
    Patton DL; Sweeney YT; Agnew KJ; Balkus JE; Rabe LK; Hillier SL
    Sex Transm Dis; 2006 Dec; 33(12):743-6. PubMed ID: 16691156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
    Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.
    Wood S; Kennedy CM; Galask RP
    J Reprod Med; 2007 Nov; 52(11):1057-8. PubMed ID: 18161407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.
    Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P
    Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Attitudes for Belgian Women With Persistent Trichomonas vaginalis Infection in the VlaResT Study.
    Donders GGG; Ruban K; Depuydt C; Bellen G; Vanden Broeck D; Jonckheere J; Jacquemyn Y
    Clin Infect Dis; 2019 Apr; 68(9):1575-1580. PubMed ID: 30395193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
    Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
    Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
    Masese LN; Graham SM; Gitau R; Peshu N; Jaoko W; Ndinya-Achola JO; Mandaliya K; Richardson BA; Overbaugh J; McClelland RS
    BMC Infect Dis; 2011 Nov; 11():307. PubMed ID: 22047086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal Tritrichomonas foetus infection in mice as an in vivo model for drug development against Trichomonas vaginalis.
    Nieskens NM; Miyamoto Y; Hurysz BM; O'Donoghue AJ; Eckmann L
    PLoS One; 2024; 19(10):e0308672. PubMed ID: 39352907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery.
    Butt S; Tirmizi A
    Int J STD AIDS; 2018 Jul; 29(8):825-827. PubMed ID: 29393008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
    Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
    Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis.
    duBouchet L; McGregor JA; Ismail M; McCormack WM
    Sex Transm Dis; 1998 Mar; 25(3):176-9. PubMed ID: 9524997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
    Kissinger P; Amedee A; Clark RA; Dumestre J; Theall KP; Myers L; Hagensee ME; Farley TA; Martin DH
    Sex Transm Dis; 2009 Jan; 36(1):11-6. PubMed ID: 19008776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.
    Sgibnev A; Kremleva E
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):345-351. PubMed ID: 31705339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.